Omega Healthcare Investors (OHI) Q4 2024 earnings summary

Executive summary

• Q4 2024 delivered continued revenue and EBITDA growth, with net income of $116 million ($0.41/share) and FAD of $0.70 per share, supporting leverage reduction below 4.0x debt to EBITDA.

• Full year 2024 net income reached $418 million ($1.55/share), with $1.1 billion deployed across 36 transactions and an active acquisition pipeline for 2025.

• Management changes included naming Matthew Gourmand as President and Vikas Gupta as CIO.

• Issued $438 million in equity in Q4 and $1.2 billion for the year, repaid $400 million in senior unsecured notes, and extended credit facility maturities.

Financial highlights

• Q4 2024 revenue was $279.3 million, up from $239 million in Q4 2023, driven by new investments and operator restructurings.

• Nareit FFO for Q4 was $196 million ($0.68/share), AFFO $214 million ($0.74/share), and FAD $202 million ($0.70/share), all up year-over-year.

• Q4 expenses decreased by $36.2 million year-over-year, mainly due to lower credit loss provisions and reduced acquisition costs.

• Full year 2024 revenues totaled $1.1 billion, up $101.7 million from 2023, with expenses falling by $144.7 million.

• Q4 FAD slightly exceeded Q3 despite significant share issuances.

Outlook and guidance

• 2025 AFFO guidance is $2.90–$2.98 per share, reflecting Q1 dilution from share issuances, recent acquisitions, and asset sales.

• Guidance assumes no change in revenue from operators on accrual basis, $56 million in asset sales, and repayment of $230 million secured debt in November 2025.

• Sufficient cash is expected to be on hand to repay the $600 million bond maturing in January 2026.